Logiscreen

Myriad Genetics Inc

$4.57
Market Cap 427.33M
ROE -109.1%
Gross Margin 68.7%
Debt/Equity 0.6
Current Ratio 2.4
Revenue QoQ 2.3%
EPS QoQ 0.0%
F-Score 2

About

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs.

Exchange
NASDAQ
Sector
Healthcare
Industry
Diagnostics & Research

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-1.10
vs median 31.50
P/B
1.30
vs median 2.17
ROE
-1.09
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics